Augmentation of anti-Fas antibody-mediated apoptosis on human glioma cells by liposomes associated with the antibody

Journal of Neuro-Oncology

Volumn 35, Issue 1, 1997, Pages 7-11

  Ohta, Seiji ^a   Mizuno, Masaaki ^a,b   Takaoka, Toru ^a   Yoshida, Jun ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Anti Fas antibody; Apoptosis; Glioma; Liposome

Indexed keywords

ANTIBODY; FAS ANTIGEN; LIPOSOME;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; GLIOMA CELL; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; GLIOMA; HUMANS; LIPOSOMES; TUMOR CELLS, CULTURED;

EID: 0030752264     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005843600950     Document Type: Article

References (14)

1. Yoshida J, Kajita Y, Wakabayashi T, Sugita K: Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumour resection and postoperative adjuvant therapy with Interferon, ACNU and radiation. Acta Neurochir (Wien) 127: 55-59, 1994
2. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756, 1989
3. Schulze-Osthoff K, Krammer PH, Droge W: Divergent signaling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13: 4587-4596, 1994
4. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993
5. Weller M, Frei K, Groscurth PH, Yonekawa Y, Fontana A: Anti-Fas antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964, 1994
6. Weller M, Malipiero U, Rensing-Ehl A, Barr PJ, Fontana A: Fas gene transfer for human malignant glioma. Cancer Res 55: 2936-2944, 1995
7. Yagi K, Noda H, Kurono M, Ohishi N: Efficient gene transfer with less than cytotoxicity by means of cationic multilamellar liposomes. Biochem Biophys Res Commun 196: 1042-1048, 1993
8. Yoshida J, Mizuno M: Simple preparation and characterization of cationic liposomes associated with a monoclonal antibody against glioma-associated antigen (immunoliposomes). J Liposome Res 5: 981-995, 1995
9. Kato K, Yoshida J, Mizuno M, Sugita K, Emi N: Retroviral transfer of herpes simplex thymidine kinase gene into glioma cells caused targeting of gancyclovir cytotoxic effect. Neurol Med Chir (Tokyo) 34: 339-344, 1994
10. Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, Koshizaka T, Yagi K: Growth inhibition of glioma cells transfected with the human β-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 50:7826-7829, 1990
11. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993
12. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619, 1993
13. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994
14. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S: Anti-Fas on nonhematopoietic tumors: Levels of Fas and bcl-2 are not predictive of biological responsiveness. Cancer Res 54: 1580-1586, 1994